OverviewChartNewsTraderScreen

UniCredit Aktienanleihe QIA 28.03.../  DE000UG1D050  /

Stuttgart
1/23/2025  9:57:07 AM Chg.+0.160 Bid9:59:06 PM Ask9:59:06 PM Underlying Strike price Expiration date Option type
101.410EUR +0.16% 99.860
Bid Size: 60,000		 100.460
Ask Size: 60,000		 QIAGEN NV 44.00 - 3/28/2025 Call
GlobeNewswire 8/28/2024 QIAGEN expands QIAstat-Dx into precision medicine through partnership for companion diagnostics in c...
TeleTrader 8/26/2024 Europe closes mixed amid Middle East crisis
GlobeNewswire 7/31/2024 QIAGEN delivers solid performance and exceeds outlook for Q2 2024
GlobeNewswire 7/31/2024 Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of Operations
GlobeNewswire 7/8/2024 QIAGEN to enhance the identification of human remains of Indigenous people and African Americans
GlobeNewswire 7/2/2024 QIAGEN N.V. to release results for Q2 2024 and hold webcast
GlobeNewswire 6/27/2024 QIAGEN welcomes new U.S. guidelines for use of QuantiFERON-TB Gold Plus in detecting tuberculosis in...
GlobeNewswire 6/17/2024 QIAGEN announces 2028 strategy for solid profitable growth
GlobeNewswire 6/13/2024 QIAGEN’s software QCI Interpret accelerates clinical reporting turnaround time for high throughput N...
GlobeNewswire 6/12/2024 QIAGEN publishes 2023 sustainability report, highlighting progress on ESG goals and commitment to su...
GlobeNewswire 6/11/2024 QIAGEN launches new QIAcuity digital PCR assays for microbial applications, enhancing infectious dis...
GlobeNewswire 6/6/2024 QIAGEN to discontinue NeuMoDx integrated PCR testing system, support customers during transition per...
GlobeNewswire 6/5/2024 QIAGEN launches digital PCR Assay Design Tool for QIAcuity, expands customization capabilities of it...
GlobeNewswire 6/3/2024 QIAGEN expands QIAstat-Dx syndromic testing menu in the U.S. with launch of molecular test to improv...
GlobeNewswire 5/30/2024 QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global...
GlobeNewswire 5/30/2024 QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global...
GlobeNewswire 5/29/2024 QIAGEN launches new library preparation kit, facilitating multiomic studies and advancing precision ...
GlobeNewswire 5/22/2024 deepull appoints Didier Deltort to its Board of Directors
GlobeNewswire 5/14/2024 QIAGEN receives European IVDR certification for QIAGEN Clinical Insight Interpret, its medical devic...
GlobeNewswire 5/13/2024 QIAGEN receives FDA clearance for QIAstat-Dx respiratory syndromic testing panel for fast and accura...
GlobeNewswire 5/7/2024 QIAGEN partners with FBI to develop digital PCR assay for QIAcuity for use in forensics
GlobeNewswire 5/7/2024 Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire 5/7/2024 Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire 5/2/2024 QIAGEN enhances bioinformatics workflows with new secondary analysis solution for oncology and inher...
GlobeNewswire 4/29/2024 QIAGEN reports results for Q1 2024 ahead of outlook, on track to achieve full-year 2024 guidance